Medicus Pharma Ltd.
MDCX
$1.73
-$0.19-9.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.78% | 46.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.52% | 17.36% | |||
| Operating Income | -11.52% | -17.36% | |||
| Income Before Tax | -238.98% | -21.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -238.98% | -21.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -238.98% | -21.04% | |||
| EBIT | -11.52% | -17.36% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -159.88% | -3.74% | |||
| Normalized Basic EPS | -49.48% | -0.38% | |||
| EPS Diluted | -159.88% | -3.74% | |||
| Normalized Diluted EPS | -49.48% | -0.38% | |||
| Average Basic Shares Outstanding | 30.43% | 16.70% | |||
| Average Diluted Shares Outstanding | 30.43% | 16.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||